Skip to content

Exercise Program for Arteriovenous Fistula Maturation

Benefits of a Perioperative Exercise Program on Maturation of Dialysis Arteriovenous Fistulas

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04034433
Acronym
FAVULOUS
Enrollment
40
Registered
2019-07-26
Start date
2019-10-04
Completion date
2026-01-26
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Fistula

Keywords

Arteriovenous Fistula Diameter, Handgrip, Program exercise, Maturation

Brief summary

Arteriovenous fistula (AVF) is the recommended vascular access for chronic hemodialysis, as it is associated with less mortality and better patency than arteriovenous graft (AVG) or central venous catheter (CVC). Unfortunately, AVF suffers from a high failure rate, due, in part, to poor venous diameter. The aim of this study is to investigate whether a perioperative handgrip training can improve the diameter of AVF in patients with chronic kidney disease (CKD) (stage IV-V).

Interventions

PROCEDUREHandgrip exercise program

Handgrip exercise with a rubber ball 4 weeks before the surgery until 4 weeks after the surgery 20 contractions per minute for a total of 20 minutes each day.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years * with chronic kidney disease (Estimated Glomerular Filtration Rate (eGFR) \<30 milliLiter/minute (mL/min)) * with follow-up at the University Hospital of Lyon Sud * who choose hemodialysis as renal replacement therapy

Exclusion criteria

* contraindication for arteriovenous fistula (AVF) surgery * refusing AVF creation * prior vascular access * antecedent of IV substance abuse * active cancer * inability to perform handgrip exercise * physical or mental disability limiting follow-up possibility * inclusion in an other interventional study * no social welfare

Design outcomes

Primary

MeasureTime frameDescription
Arteriovenous Fistula (AVF diameter)at 6 weeks (after surgery)Arteriovenous Fistula diameter will be measured by Doppler ultrasound

Secondary

MeasureTime frameDescription
Echographic maturation rateat 6 weeks (after surgery)Maturation rate of Arteriovenous Fistula (AVF) by echography defined as blood flow\>600milliLiters/minute (mL/min), diameter\>6millimeters (mm) and depth \<6mm
Clinical maturation rateat 6 weeks (after surgery)Arteriovenous Fistula (AVF) measured by a vein easily palpable, relatively straight, with a uniform sensation of quivering and more than 10centimeters (cm) long.
Arteriovenous Fistula (AVF) localization (arm or forearm)at 6 weeks (after surgery)After the patient's examination, the vascular surgeon will choose the future AVF localization
Arteriovenous Fistula (AVF) interventionsup to 6 weeksNecessity of performing an intervention (such as angioplasty or thrombolysis or thrombectomy or superficialization) on the Arteriovenous Fistula (AVF)
Emergency hemodialysis on Central Venous Catheter (CVC)up to 6 weeksNecessity of patients on CVC to undergo emergency hemodialysis
Emergency hemodialysis on Arteriovenous Graft (AVG)up to 6 weeksNecessity of patients on AVG to undergo emergency hemodialysis

Countries

France

Contacts

PRINCIPAL_INVESTIGATORAbbas DEEB, PhD

Hospices Civils de Lyon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026